| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
21,040,000 |
| Market
Cap: |
1.00(B) |
| Last
Volume: |
64,582 |
Avg
Vol: |
95,707 |
| 52
Week Range: |
$41.52 - $67.92 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ INDUSTRIAL |
|
S&P SMALLCAP 600 |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile USANA Health Sciences develops and manufactures science-based nutritional, personal care and skincare products. Co.'s principal product lines include: USANA® Nutritionals Optimizers, which consists of targeted supplements designed to meet individual health and nutritional needs; Essentials/CellSentials®, which includes primary vitamin and mineral supplements that provide a foundation of body nutrition for every age group with children 13 months of age; Foods, which includes meal replacement shakes, snack bars, and other related products that provide macro-nutrition in various formats; and Personal Care and Skincare, which includes its science-based personal care products and Celavive.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
45,419 |
45,731 |
62,314 |
140,742 |
| Total Sell Value |
$2,164,898 |
$2,180,413 |
$3,239,295 |
$8,241,627 |
| Total People Sold |
11 |
11 |
14 |
16 |
| Total Sell Transactions |
13 |
14 |
25 |
50 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sinnott Robert A |
Chief Scientific Officer |
• – – |
2021-08-17 |
4 |
OE |
$65.48 |
$490,576 |
D/D |
7,492 |
7,492 |
|
- |
|
| Sinnott Robert A |
Chief Scientific Officer |
• – – |
2021-08-16 |
4 |
S |
$95.04 |
$156,626 |
D/D |
(1,648) |
0 |
|
-7% |
|
| Sinnott Robert A |
Chief Scientific Officer |
• – – |
2021-08-16 |
4 |
OE |
$65.48 |
$107,911 |
D/D |
1,648 |
1,648 |
|
- |
|
| Fuller Gilbert A |
Director |
– • – |
2021-08-05 |
4 |
S |
$96.52 |
$30,114 |
D/D |
(312) |
0 |
|
-5% |
|
| Foukas Joshua |
Chief Legal Officer |
• – – |
2021-08-05 |
4 |
S |
$97.07 |
$24,170 |
D/D |
(249) |
0 |
|
-5% |
|
| Winssinger Frederic J |
Director |
– • – |
2021-07-29 |
4 |
S |
$99.08 |
$91,748 |
D/D |
(926) |
1,590 |
|
-3% |
|
| Auciaux Robert |
Director |
– • – |
2021-07-28 |
4 |
D |
$99.83 |
$9,384 |
D/D |
(94) |
516 |
|
- |
|
| Auciaux Robert |
Director |
– • – |
2021-07-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
312 |
610 |
|
- |
|
| Fuller Gilbert A |
Director |
– • – |
2021-07-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
312 |
312 |
|
- |
|
| Winssinger Frederic J |
Director |
– • – |
2021-07-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
312 |
2,516 |
|
- |
|
| Wood Timothy E |
Director |
– • – |
2021-07-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
312 |
738 |
|
- |
|
| Fleming John Turman |
Director |
– • – |
2021-07-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
312 |
1,151 |
|
- |
|
| Pelosi Peggie |
Director |
– • – |
2021-07-28 |
4 |
D |
$99.83 |
$13,577 |
D/D |
(136) |
1,736 |
|
- |
|
| Pelosi Peggie |
Director |
– • – |
2021-07-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
312 |
1,872 |
|
- |
|
| Foukas Joshua |
Chief Legal Officer |
• – – |
2021-07-23 |
4 |
D |
$101.18 |
$18,516 |
D/D |
(183) |
249 |
|
- |
|
| Foukas Joshua |
Chief Legal Officer |
• – – |
2021-07-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
432 |
432 |
|
- |
|
| Neidig Brent |
Chief Officer & MD of China |
• – – |
2021-06-18 |
4 |
S |
$102.17 |
$26,462 |
D/D |
(259) |
0 |
|
1% |
|
| Auciaux Robert |
Director |
– • – |
2021-06-17 |
4 |
S |
$101.72 |
$60,625 |
D/D |
(596) |
298 |
|
2% |
|
| Iiekking G Doug |
CFO |
• – – |
2021-06-01 |
4 |
S |
$106.97 |
$54,660 |
D/D |
(511) |
1,400 |
|
10% |
|
| Fuller Gilbert A |
Director |
– • – |
2021-05-05 |
4 |
S |
$93.08 |
$39,651 |
D/D |
(426) |
0 |
|
6% |
|
| Iiekking G Doug |
CFO |
• – – |
2021-05-01 |
4 |
D |
$89.99 |
$33,836 |
D/D |
(376) |
1,911 |
|
- |
|
| Iiekking G Doug |
CFO |
• – – |
2021-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
887 |
2,287 |
|
- |
|
| Neidig Brent |
Chief Officer & MD of China |
• – – |
2021-04-29 |
4 |
D |
$87.64 |
$18,229 |
D/D |
(208) |
260 |
|
- |
|
| Neidig Brent |
Chief Officer & MD of China |
• – – |
2021-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
467 |
467 |
|
- |
|
| Wood Timothy E |
Director |
– • – |
2021-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
426 |
426 |
|
- |
|
2038 Records found
|
|
Page 18 of 82 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.31 (0.66%) 
